B dot Medical to Install Its First Practical Ultra-compact Proton Therapy System at Hospital

in Tokyo - Memorandum of Understanding Signed with Edogawa Hospital -

B dot Medical

TOKYO, Jan. 5, 2023 /Kyodo JBN/ --

B dot Medical Inc.

B dot Medical Inc. has signed a memorandum of understanding with Edogawa Hospital in Japan for the installation of the company's first practical ultra-compact proton therapy system, which means the first proton therapy facility to be established in Tokyo.

 

Logo: https://kyodonewsprwire.jp/img/202212211482-O2-n1O2n8B4

 

Image1: Edogawa Hospital in Tokyo, Japan

https://kyodonewsprwire.jp/prwfile/release/M105528/202212211482/_prw_PI3fl_q4R7xNxK.jpeg

 

Conventional proton therapy systems are very large and require a large space for installation. As a result, the installation of proton therapy in urban areas where land is scarce has been slow, and proton therapy has reached only a small percentage of patients. To overcome this situation, B dot Medical is working to commercialize an ultra-compact proton therapy system. This system is overwhelmingly more compact than conventional ones and can be installed in hospitals where it has been difficult to do it due to the size and cost of the system in the past.

 

Dr. Shojiro Kato, Director of Edogawa Hospital, commented: "We are very pleased that once our hospital is able to offer proton therapy, we will be able to treat patients who have not previously been able to receive proton therapy in Tokyo. We will continue to provide medical care in pursuit of the best possible outcome for all patients."

 

Takuji Furukawa, Chief Executive Officer of B dot Medical, added: "Three and a half years have passed since we started developing an ultra-compact proton therapy system to bring more advanced cancer treatment to as many patients as possible, and we are finally one step closer to realizing our dream. We hope that the installation of this system will expand the treatment options for many cancer patients. We will do our utmost to obtain approval for the system, install it, start treatment, and provide support afterward."

 

B dot Medical will continue its efforts to obtain PMDA (Pharmaceuticals and Medical Devices Agency) approval in Japan, aiming for a society in which cancer patients around the world can choose proton therapy.

 

About B dot Medical Inc.

B dot Medical Inc. is a start-up that originated at the National Institute of Radiological Sciences (NIRS) and is developing an ultra-compact proton therapy system by utilizing the advanced technology and experience cultivated at NIRS. The company is challenging the world with Japanese technological innovation power.

 

Image2: Ultra-compact proton therapy system under development

https://kyodonewsprwire.jp/prwfile/release/M105528/202212211482/_prw_PI4lg_1i4xoCzD.jpg

 

Company Information

Name: B dot Medical Inc.

Address: 5-10-10 Harue-cho, Edogawa-ku, Tokyo 134-0003 JAPAN

Representative: Takuji Furukawa, President and CEO

Foundation: March 1, 2017

Business activity:

1) Consulting support for particle therapy

2) Developing proton therapy systems

 

Website: https://bdotmed.co.jp/en/

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

プレスリリース添付画像

| Small | Normal |
| Original |

Edogawa Hospital in Tokyo, Japan

| Small | Normal |
| Big | Original |

Ultra-compact proton therapy system under development

| Small | Normal |
| Big | Original |

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

このプレスリリースを配信した企業・団体

  • 名称 株式会社ビードットメディカル
  • 所在地 東京都
  • 業種 電気機器
  • URL http://bdotmed.co.jp/
  • ※購読している企業の確認や削除はWebプッシュ通知設定画面で行なってください
  • SNSでも最新のプレスリリース情報をいち早く配信中

    過去に配信したプレスリリース